Navigation Links
Research links telomere length to emphysema risk

Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to research from Johns Hopkins University.

"We found that in mice that have short telomeres, there was a significant increased risk of developing emphysema after exposure to cigarette smoke," said Mary Armanios, MD, assistant professor of oncology at the Johns Hopkins School of Medicine.

The study appears online ahead of the print edition of the American Journal of Respiratory and Critical Care Medicine.

Telomeres are DNA protein structures that protect chromosome ends from degradation. Their length is genetically determined, but they also shorten progressively with cell division. Short telomeres are considered one marker of ageing in cells.

"With age, short telomeres accumulate and cause cells to stop dividing. Telomeres can be thought of as 'biological clocks,'" Dr. Armanios explained. "We wanted to determine whether telomere length itself was why susceptibility to emphysema increases with age."

Dr. Armanios and her colleagues examined the role of telomeres in lung disease by studying mice that have shortened telomeres. The mice were exposed to cigarette smoke for six hours a day, five days a week for six months.

The researchers then analyzed the lung tissue and pulmonary function of the mice. "Although the mice had no lung disease at baseline, after exposure to cigarette smoke, they surprisingly developed emphysema. In contrast, mice with long telomeres did not develop lung disease during our experiments," said Dr. Armanios.

In emphysema, alveoli, the small air sacs where oxygen exchange occurs, are permanently lost. Emphysema changes are normally found in older individuals, and occasionally even in those who have never smoked. But they are most commonly found in smokers.

Emphysema is a common cause of disability, and among the top 10 causes of mortality in the United States, it remains on the increase. While smoking cigarettes is the most common risk factor, it is not known why some people are more prone to developing emphysema than others. There are currently no available medical treatments, and affected individuals often require lung transplantation.

"We found that cells with damaged DNA stopped dividing, and lung cells with too much damage could no longer be repaired, thus contributing to the emphysema," she continued. "These results are one of the clearest examples of telomere length, which is an inherited factor, interacting with an environmental insult to cause disease. In fact, our results in mice suggest that short telomeres might contribute to how cigarette smoke accelerates aging in the lung in some individuals."

Dr. Armanios hopes that this new research will lead into new insights into identifying new ways to preserve lung function with age.

"It's important to remember that there is no good reason to smoke and the best way to prevent emphysema is to stop smoking," she said.

Previously, Dr. Armanios and her group had shown that shortened telomeres cause a disease known as idiopathic pulmonary fibrosis (IPF), a disorder of unrelenting scarring in the lung. IPF occurs with emphysema in some individuals, and the incidence of both disorders increases with age and with smoking. "By linking telomere length to both disorders, there is now clear suggestion that they may share a common mechanism that can be traced to telomeres."

Further research must be done to confirm that the observed findings are applicable to humans, and, if so, what mechanisms might underlie them. "Now that we have examined the question of susceptibility in a rigorous genetic model, we can begin to study how telomere length affects emphysema risk in susceptible populations."


Contact: Keely Savoie
American Thoracic Society

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. NC State researchers get to root of parasite genome
3. White Mountain Research Station to host climate change conference
4. Stevens awarded $1M for advanced biofuels research
5. Researchers find animal with ability to survive climate change
6. Researchers find an essential gene for forming ears of corn
7. Researchers note differences between people and animals on calorie restriction
8. Researcher working on destruction of chemical weapons
9. Researchers study acoustic communication in deep-sea fish
10. Researchers discover that growing up too fast may mean dying young in honey bees
11. The Rett Syndrome Research Trust launches operations
Post Your Comments:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: ... for financial services, but it also plays a fundamental part ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology: